However, it is interesting that MKL-1 and STAT3 can also elevate the expression of Vimentin, and meanwhile, miR-93-5p has also been reported to inhibit the expression of MKL-1 and STAT3 therefore inhibiting EMT in breast cancer [27]. Here, MRTFA is linked to breast carcinoma.